Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Mangoceuticals (MGRX) Accumulated Depreciation & Amortization (2022 - 2025)

Mangoceuticals' Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $758.0 for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 92.17% to $758.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $758.0, a 92.17% decrease, with the full-year FY2024 number at $9936.0, down 60.08% from a year prior.
  • Accumulated Depreciation & Amortization hit $758.0 in Q3 2025 for Mangoceuticals, up from $502.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for MGRX hit a ceiling of $24889.0 in Q4 2023 and a floor of -$112437.0 in Q4 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged -$2034.2 across 4 years, with a median of $6153.0 in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 122.14% in 2023 and later crashed 95.98% in 2025.
  • Tracing MGRX's Accumulated Depreciation & Amortization over 4 years: stood at -$112437.0 in 2022, then soared by 122.14% to $24889.0 in 2023, then crashed by 60.08% to $9936.0 in 2024, then crashed by 92.37% to $758.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for MGRX at $758.0 in Q3 2025, $502.0 in Q2 2025, and $250.0 in Q1 2025.